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Edited by Lukas HuberAbstract This study demonstrates that activation of d-opioid
receptors (DORs) in neuroblastoma · glioma (NG108-15) hy-
brid cells by [D-Ala2, D-Leu5]enkephalin (DADLE) and etor-
phine signiﬁcantly enhances cell adhesion to ﬁbronectin-coated
wells. This eﬀect is blocked by both naloxone and integrin bind-
ing RGDT peptides. In addition, cell adhesion turned out to be a
prerequisite for DOR-stimulated transactivation of Tropomyo-
sin-related kinase A (TrkA) and extracellular signal-regulated
kinases 1/2 (ERK1/2). Because inhibition of TrkA activation
by AG879 completely blocked DOR- and integrin-mediated
ERK1/2 signaling, the present results indicate that in NG108-
15 cells DOR-stimulated ERK1/2 activation is mediated by inte-
grin-induced transactivation of TrkA.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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related kinase A1. Introduction
d-Opioid receptors (DORs) belong to the family of G pro-
tein-coupled receptors that bring about their action by stimu-
lation of inhibitory G proteins [1]. Acute DOR activation
results in attenuation of neuronal excitability, which is medi-
ated by inhibition of adenylyl cyclase activity, voltage-depen-
dent calcium channels or activation of inwardly rectifying
potassium conductances [2]. Besides these classical eﬀector sys-
tems, a number of studies indicate that DORs may also couple
G proteins of the Gq/11, G12/13 and G14 family, which regulate
more complex intracellular signaling pathways, such as the
extracellular signal-regulated kinases 1/2 (ERK1/2) or the
PI3K/Akt cascade [3]. These signaling pathways are thought
to contribute to long-term opioid eﬀects, such as tolerance/
dependence [4], impaired learning and memory behavior [5]
or increased neuroprotection and cell survival [6,7].
Another non-classical aspect of opioid action has been re-
cently identiﬁed for peripheral DORs. Pello et al. [8] demon-
strated that incubation of monocytes with the DOR agonistAbbreviations: DADLE, [D-Ala2, D-Leu5]enkephalin; DOR, d-opioid
receptor; EGF, epidermal growth factor; ERK, extracellular signal-
regulated protein kinase; FN, ﬁbronectin; NG108-15 cells, neuroblas-
toma · glioma (NG108-15) hybrid cells; TrkA, tropomyosin-related
kinase A
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doi:10.1016/j.febslet.2008.08.021[D-Ala2, D-Leu5]enkephalin (DADLE) triggers cell adherence
to the extracellular matrix (ECM) protein ﬁbronectin (FN),
an eﬀect that is mediated by activation of integrins. Integrins
are a large family of heterodimeric, transmembrane cell-sur-
face glycoproteins originally identiﬁed as mediators of cell
adhesion and migration [9]. Besides their regulatory eﬀect on
the rearrangement of the cytoskeleton, certain integrin dimers
may also inﬂuence cell proliferation and growth by activation
of mitogenic signal transduction pathways [10]. Although
DOR-stimulated cell adhesion is thought to play a critical role
in leukocyte traﬃcking [8], the intracellular pathways mediat-
ing this integrin-stimulated processes are still unknown. Be-
cause integrins regulate opioid receptor signaling in
trigeminal ganglion neurons [11] and modulate G protein-cou-
pled receptor signaling to ERK1/2 [12], the present study was
performed in order to investigate whether DOR activation also
results in stimulation of cell adhesion and regulation of intra-
cellular ERK1/2 signaling in neuronal cells.2. Materials and methods
2.1. Materials
An original stock of NG108-15 hybrid cells was obtained from the
American Type Culture Collection (ATCC). Ligands and chemical
inhibitors were from the following companies and institutions: DA-
DLE, Bachem; etorphine, National Institutes of Health; naloxone,
RGDT peptides AG879, AG1478, BPIQ-I, Merck/Calbiochem. All
primary antibodies were purchased from New England Biolabs, horse-
radish peroxidase-conjugated donkey anti-rabbit IgG was from
Promega.
2.2. Cell culture
NG108-15 cells were cultured as described in Dulbecco´s modiﬁed
Eagle Medium (DMEM), supplemented with 10% fetal calf serum
(FCS), 100 lM hypoxanthine, 1 lM aminopterin, and 16 lM thymi-
dine, at 37 C in a humidiﬁed atmosphere of 5% CO2 in air [13].
2.3. Cell adhesion assay
This was done according to the procedure described for monocytes
[8]. Brieﬂy, NG108-15 hybrid cells grown in log phase were detached,
washed and resuspended into serum-free culture medium. Cells
(1 · 105) were seeded onto FN (0.5 ng/well)-coated 96-well plates and
allowed to adhere for 1 h at RT either in the absence (control) or pres-
ence of DADLE (1 lM) and etorphine (0.1 lM). Non-speciﬁc binding
was blocked by preincubation of the plates with 2% (m/v) BSA for
30 min at RT. In some experiments, cells were pretreated with nalox-
one (10 lM, 10 min) or RGDT peptides (1 mM, 60 min). Incubations
were stopped by bottom-up centrifugation of the plates (30 · g, 5 min)
and subsequent ﬁxation of adherent cells with 4% (m/v) paraformalde-
hyde solution. Cells were stained with 0.1% (m/v) crystal violet, solubi-
lised with Triton-X-100 and color reaction was photometrically
measured at k = 570 nm in a Tecan Spectra multiplate reader. Each
experiment was done in triplicate determination.blished by Elsevier B.V. All rights reserved.
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Subconﬂuent cells grown on 12-well plates were serum starved for
2 h before experiments were conducted. In some experiments, integrin
(RGDT peptides, 1 mM) as well as receptor tyrosine kinase inhibitors
(AG1478, 5 lM; BPIQ-I, 10 lM; AG879, 100 lM) were added during
the preincubation period for 30 and 15 min, respectively. Cells were
stimulated for 5 min at 37 C in the presence of various opioids at
the concentrations indicated. Reactions were stopped by aspiration
of the medium and the addition of 150 ll of ice-cold Laemmli sample
buﬀer (62.5 mM Tris–HCl, pH 6.8, 2% SDS, 10% glycerol, 50 mM
DTT, and 0.01% phenol red).2.5. Western blot
Solubilized proteins were resolved by electrophoresis over 10% (m/v)
SDS–polyacrylamide gels, transferred to PVDF-membranes and sub-
jected to immunoblot detection as described [14]. Overall abundance
of ERK1/2 was evaluated using a pan-reactive ERK1/2 antibody,
whereas activated ERK1/2 was determined by a phospho-speciﬁc
Thr202/Tyr204 antibody (1:1000 each). Activated TrkA was deter-
mined by a phospho-Tyr490 speciﬁc antibody (1:1000). The blots were
incubated with horseradish peroxidase-conjugated donkey anti-rabbit
IgG (1:15000) and subsequently developed using enhanced chemilumi-
nescence (Amersham). The intensity of immunoreactive bands was
evaluated using a Herolab E.A.S.Y. RH-5 video densitometer.3. Results and discussion
3.1. d-Opioid receptors stimulate NG108-15 cell adhesion
To investigate a possible involvement of integrins in DOR-
stimulated ERK1/2 activity, the eﬀect of opioids on cell adhe-
sion, a typical integrin-mediated process, was determined in
NG108-15 hybrid cells. This cell line has a long history inFig. 1. DOR activation enhances NG108-15 cell adhesion. NG108-15 cells
(Cn) or presence of DADLE (1 lM) and etorphine (100 nM). Incubations
determined. (A) Microscopic images taken from control and DADLE-treate
exposed cells. (B) Quantiﬁcation of adherent cells by crystal violet stainin
treatment by about 5-fold. This opioid eﬀect is completely blocked by coi
peptides. The results shown are the means ± S.E.M. values from three indepinvestigating acute and chronic opioid actions and carries high
levels of endogenous a5/b1 integrins that associate with gangli-
oside GM1 thereby modulating DOR activity [15]. In experi-
ments similar to that previously conducted with monocytes
[8], NG108-15 cells were seeded onto ﬁbronectin (FN)-coated
wells and incubated for 5 min either in the absence or presence
of DADLE (1 lM) to allow cell adhesion. As shown in
Fig. 1A, opioid treatment substantially increased the number
of cells bound to the integrin ligand FN. In addition, DADLE
treatment also resulted in the formation of spines in some
NG108-15 cells (Fig. 1A, arrows). Quantiﬁcation of adherent
cells veriﬁed that DADLE treatment indeed signiﬁcantly stim-
ulates cell adhesion by about 5-fold as compared to untreated
controls (Fig. 1B). A similar eﬀect was observed for the opioid
alkaloid etorphine (100 nM, 5 min), indicating that stimulation
of cell adhesion is not restricted to peptide agonists (Fig. 1B).
Opioid-stimulated NG108-15 cell adhesion was abolished by
coincubation of the cells with both the competitive opioid
receptor antagonist naloxone (10 lM, 10 min) as well as inte-
grin blocking RGDT peptides (1 mM, 12 h). These ﬁndings
suggest that opioids possess the capacity to stimulate cell adhe-
sion not only in monocytes [8], but also in cells of neuronal ori-
gin. In addition, they also indicate that opioid-induced binding
of NG108-15 cells to FN is mediated by a5/b1 integrins, two
integrin isoforms abundant in neuronal cells and responsible
for dendritic spine formation in hippocampal neurons
[16,17]. Because activation of integrins may result in cell prolif-
eration [9], we next investigated whether DOR-stimulated cell
adhesion is associated with activation of the ERK1/2 signaling
pathway.were plated onto FN-coated wells and incubated either in the absence
were stopped by bottom-up centrifugation before cell adhesion was
d cells. Arrows indicate the formation of spines in some of the opioid
g. Cell binding to FN is stimulated by both DADLE and etorphine
ncubation with 10 lM naloxone or pretreatment with 1 mM RGDT
endent experiments. ***Signiﬁcantly diﬀerent at P < .001.
Fig. 3. DOR-stimulated ERK1/2 activation is mediated by transacti-
vation of TrkA. NG108-15 cells were pretreated with inhibitors for the
EGF receptor (AG1478, 5 lM; BPIQ-I, 10 lM) or TrkA (AG879,
100 lM) before DADLE- (1 lM; DA) and etorphine (100 nM; Eto)-
stimulated ERK1/2 activation was determined. Inhibition of TrkA, but
not of the EGF receptor, completely blocks DOR-stimulated ERK1/2
activity. The blots shown are representative for at least three
independent experiments yielding similar results.
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Exposure of NG108-15 cells to DADLE and etorphine re-
sults in activation of ERK1/2, as demonstrated by an activa-
tion-speciﬁc antibody recognizing phosphorylated Thr202/
Tyr204 residues (Fig. 2). To investigate whether integrin-med-
iated cell adhesion also results in ERK1/2 activation, NG108-
15 cells were pretreated with RGDT peptides and subsequently
measured for DOR-stimulated ERK1/2 activity. Most interest-
ingly, blockade of cell adhesion to FN by integrin binding
RGDT peptides completely prevented opioid-induced ERK1/
2 signaling. A similar blockade of ERK1/2 signaling was also
observed when the DOR-mediated eﬀect was investigated in
suspension culture (Fig. 2). These ﬁndings are in line with
the observation that integrin-mediated cell adhesion is associ-
ated with mitogenic signaling [18] and suggest that integrins
represent an essential prerequisite for DOR-stimulated
ERK1/2 activation.
3.3. Cell adhesion stimulates ERK1/2 signaling by
transactivation of TrkA receptors
Previous studies revealed that ERK1/2 activation by inte-
grin-mediated cell adhesion involves transactivation of epider-
mal growth factor (EGF) receptors in epithelial cells [19].
Therefore, we investigated whether a similar signaling pathway
might also account for DOR-stimulated, integrin-dependent
ERK1/2 activation in NG108-15 cells. Although in stably
transfected HEK293 cells DOR-stimulated ERK1/2 signaling
is mediated by transactivation of EGF receptors [13], pre-incu-
bation of NG108-15 cells with the selective EGF receptor
blockers AG1478 [20] and BPIQ-I [21] failed to attenuate DA-
DLE- and etorphine-stimulated ERK1/2 activation (Fig. 3).
This ﬁnding demonstrates that in NG108-15 cells integrin-
mediated stimulation of the Ras/Raf/ERK1/2 cascade is inde-
pendent of EGF receptors. It also implicates that HER2/NEU
receptors, which might enhance EGFR signaling by formation
of functional heterodimers with EGF receptors, are not in-
volved in opioid-stimulated ERK1/2 signaling [22].
The TrkA receptor represents another member of the super-
family of receptor tyrosine kinases that has been previously
shown to link distinct G protein-coupled receptors to the
ERK1/2 signaling pathway [23]. Therefore, we tested the eﬀectFig. 2. DOR-stimulated ERK1/2 activation is integrin dependent.
NG108-15 cells were stimulated for 5 min with DADLE (1 lM; DA)
and etorphine (100 nM; Eto) before ERK1/2 activation was deter-
mined by Western blot using a phospho-speciﬁc antibody (bottom
panel). Equal protein load was veriﬁed by incubation with an overall
reactive ERK1/2 antibody (top panel). Short-term DOR activation
with DADLE and etorphine results in strong ERK1/2 phosphoryla-
tion, an eﬀect that is completely blocked by preincubation of the cells
with RGDT peptides or determination of ERK1/2 activity in suspen-
sion culture. The blots shown are representative for at least three
independent experiments yielding similar results.of the speciﬁc TrkA inhibitor AG879 [21] on DOR-mediated
ERK1/2 activation. Indeed, preincubation of the cells with
AG879 completely prevented-opioid induced ERK1/2 phos-
phorylation (Fig. 3).
3.4. DOR-mediated transactivation of TrkA is dependent on
integrin function
Because cell adhesion results in activation of integrins [18]
and facilitates DOR-stimulated ERK1/2 signaling, we ﬁnally
examined whether integrins are involved in DOR-mediated
transactivation of the TrkA/ERK1/2 signaling module. For
this, the role of cell adhesion in DADLE and etorphine stimu-
lated TrkA activity was determined. As shown in Fig. 4, opioid
treatment results in phosphorylation of TrkA at Tyr490, which
is indicative for receptor autophosphorylation and, hence, acti-
vation [24]. This eﬀect is blocked by integrin binding RGDT
peptides and is absent in cells kept in suspension culture during
opioid stimulation. These results indicate that DOR-mediated
cell adhesion results in transactivation of TrkA. Such a mech-
anism is supported by the possibility that integrin binding to
extracellular matrix proteins leads to transactivation of TrkA
in a src kinase dependent manner [25].Fig. 4. DOR stimulation results in integrin-dependent TrkA phos-
phorylation. NG108-15 cells were cultured for 5 min either in the
absence (Cn) or presence of DADLE (DA; 1 lM) and etorphine (Eto;
100 nM) before cells were lysed and TrkA phosphorylation was
determined by Western blot using a phospho-Tyr490 speciﬁc TrkA
antibody. Short-term opioid treatment strongly stimulates TrkA
autophosphorylation, an eﬀect that is absent in cells pretreated with
RGDT peptides measured in suspension culture (susp.). The data
shown are the means ± S.E.M. values from three independent exper-
iments.
3328 D.A. Eisinger, H. Ammer / FEBS Letters 582 (2008) 3325–33294. Conclusion
This study provides evidence that in neuroblastoma · gli-
oma NG108-15 hybrid cells DOR-stimulated mitogenic signal-
ing involves cell adhesion and is transduced by integrin-
mediated transactivation of the TrkA/ERK1/2 cascade. Inte-
grins are transmembrane ‘‘adhesion receptors’’ that usually
control cell behavior by linking mechanical extracellular stim-
uli to intracellular signal transduction pathways and the cyto-
skeleton [9]. Here we demonstrate that the DOR, a member of
the family of G protein-coupled receptors, utilize these signal-
ing components to bring about activation of the ERK1/2 cas-
cade. In the central nervous system, long-term modulation of
integrin activity plays a critical role in synaptic plasticity
[26], spatial memory [27] as well as neural survival and regen-
eration [28]. Because long-term potentiation and memory con-
solidation have also been associated with continuous
activation of the ERK1/2 signaling pathway [29], the present
ﬁndings might contribute to chronic opioid-induced synaptic
plasticity [30], improved memory and learning [5] as well as
the development of tolerance/dependence [4]. In this respect,
transactivation of TrkA receptors by opioid-induced release
of Trk agonists [31] could explain the neuroprotective proper-
ties demonstrated for some d-opioids [6] and might contribute
to the development of opioid tolerance/dependence [32]. To
conﬁrm the role of the integrin/TrkA/ERK1/2 signaling path-
way in chronic opioid-induced neuronal plasticity, additional
experiments performed on primary neurons using opioid li-
gands known for their addictive propensity (e.g. morphine)
and additional TrkA inhibitors (e.g. TrkA-blocking antibodies
[33]) will be required.
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